Estimations des analystes de Wall Street pour Biodesix, Inc. (BDSX): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Consensus des analystes
| Achat fort | 0 |
| Achat | 6 |
| Conserver | 1 |
| Vente | 0 |
| Vente forte | 0 |
| Analystes au total | 7 |
| Note moyenne (1-5) | 0.86 |
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-02 | $-0.74 | ||
| 2026-08-05 | $-0.71 | $-0.90 | +21.3% |
| 2026-05-04 | $-0.81 | $-1.26 | +35.7% |
| 2026-02-26 | $-0.49 | $-1.05 | +53.3% |
| 2025-11-03 | $-1.16 | $-1.60 | +27.5% |
| 2025-08-07 | $-1.60 | $-1.40 | -14.3% |
| 2025-05-13 | $-1.60 | $-1.40 | -14.6% |
| 2025-03-03 | $-1.20 | $-0.07 | -1614.3% |
Ratios de valorisation
| Prix / Valeur comptable | 32.11 |
| EV / EBITDA | -17.85 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenus | $20.4M | $24.6M | $45.6M | $54.5M | $38.2M | $49.1M | $71.3M | $88.5M |
| Coût des Ventes | $4.4M | $6.1M | $22.0M | $30.5M | $14.2M | $13.0M | $15.6M | $16.7M |
| Marge Brute | $16.0M | $18.5M | $23.6M | $24.0M | $24.1M | $36.1M | $55.8M | $71.8M |
| R&D | $8.2M | $10.5M | $10.8M | $12.8M | $13.1M | $10.0M | $9.6M | $12.0M |
| Frais Généraux | $25.9M | $30.6M | $34.9M | $50.5M | $61.5M | $67.4M | $80.5M | $87.5M |
| Charges Opérationnelles | $34.1M | $45.2M | $46.5M | $64.9M | $74.6M | $77.4M | $90.2M | $99.5M |
| Résultat Opérationnel | -$23.5M | -$26.7M | -$22.9M | -$40.9M | -$50.6M | -$41.3M | -$34.5M | -$27.8M |
| EBITDA | -$21.5M | -$24.9M | -$20.8M | -$35.5M | -$51.5M | -$37.1M | -$29.2M | -$21.9M |
| Charges d'Intérêt | $2.9M | $3.0M | $7.6M | $4.5M | $8.1M | $9.5M | $8.3M | $7.7M |
| Résultat Avant Impôts | -$26.2M | -$30.7M | -$31.4M | -$43.2M | -$65.4M | -$52.1M | -$42.9M | -$35.3M |
| Impôts | $211000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Résultat Net | -$26.2M | -$30.7M | -$31.4M | -$43.2M | -$65.4M | -$52.1M | -$42.9M | -$35.3M |
| BPA | $-19.72 | $-2410.66 | $-23.61 | $-31.54 | $-31.09 | $-12.70 | $-6.62 | $-4.67 |
| BPA Dilué | $-19.72 | $-2410.66 | $-23.61 | $-31.54 | $-31.09 | $-12.70 | $-6.62 | $-4.67 |
| Actions en Circulation (Diluées) | $1.3M | $1.3M | $1.3M | $1.4M | $2.1M | $4.1M | $6.5M | $7.6M |
Prix
| Prix | $28.56 |
| Capitalisation | $232M |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: ALGS · INMB · MRSN · NOTV · OKUR · PDSB · SKYE
Explorer le secteur: Healthcare · Medical - Diagnostics & Research
Plus de sections de BDSX: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions